The study aimed to evaluate the efficacy of the porcine small intestine submucosa extracellular matrix (SIS-ECM) in a murine model, as a possible vascular patch for clinical use in reconstructive vascular and potentially cardiac surgery.
INTRODUCTION
Tissue engineering represents a new approach to tissue and organ regeneration and replacement [1] . Specifically, cardiac and vascular tissue engineering is an emerging field that may hold a great promise for advancing the treatment of heart diseases [2] . Biological scaffold materials composed of extracellular matrix (ECM) have already been shown to facilitate the constructive remodelling of many different tissues in both preclinical animal studies and in human clinical applications [3] . The ECM scaffold materials are derived from a variety of tissues, including heart valves [4] , nerves [5] , skeletal muscle [6] and tendons [7] .
Based on this knowledge, the use of a biological scaffold material derived from porcine small intestine submucosa (SIS)-ECM may reflect a new type of approach. This material has been widely used in different experimental models, with encouraging results [8] . However, a clear histopathological analysis is not definitely documented.
We report on our experience with an institutional experimental murine model project, which has been designed to test the safety and efficacy of SIS-ECM as a vascular tissue substitute, and moreover to verify the tissue remodelling capabilities with accurate histopathological evaluation, in order to expand its indications to surgery for acquired and congenital heart defects in infancy and childhood.
MATERIALS AND METHODS

Small intestine submucosa
The SIS-ECM is a biological scaffold of connective tissue that is xenogenic, collagen-based, biodegradable and non-immunogenic [8] . It is supposed to be the scaffolding that provides the framework for living tissues. It is available for clinical use in many applications and is marketed under the trade name CorMatrix consists of four layers of porcine intestinal submucosa that are pressed together to a single membrane that has undergone a decellularization process with a proprietary technique, eliminating any living vital components. The thickness of the material is 100 µm. The finished material consists of collagen, glycosaminoglycans, proteoglycans, heparan sulphate and other cellsignalling molecules. The material is packaged in a dehydrated sheet form in two sizes. Rehydration is required prior to use for 10 min at room temperature in sterile saline. Once rehydrated, the material becomes pliable and can be cut and trimmed as needed to fit a variety of shapes. A 6-7 × 3-4-mm patch was prepared from the SIS-ECM material. Original patch sections were also used as a control and evaluated with histological analysis.
Animal model
The animal study was authorized by the Animal Care Committee of the Italian Ministry of Health and by the Local Ethical Committee for Animal Study at the University of Padova-Medical School. Animals employed in this study were adult male rats, Sprague Dawley wild-type ( purchased from Charles River Laboratories Italia Srl, Italy), and transgenic rats expressing the enhanced green fluorescent protein (GFP) under the control of the cytomegalovirus enhancer and the chicken beta-actin promoter. The mean weight at operation was 338 g (ranging between 190 and 412 g). All animals were kept in conventional facilities with free access to food and water. Adequate care for their health and well-being was provided in accordance with the Italian Law 116/92. The animals were acclimatized preoperatively in the Institute of Experimental Surgery, University of Padova. All animals were subdivided randomly in three groups: Group 1, early survivors (i.e. the animals were sacrificed before 45 days from operation); Group 2, late survivors (i.e. the animals were sacrificed after 45 days from operation); Group 3, GFP animals, in order to assess the cell proliferation origin (donor or recipient). In addition, three animals were used as natural control and three were included in the sham-operated group as surgical controls, so as to ensure that they were reflecting the effects of the experiment itself, and were not merely a consequence of surgery.
Surgical technique and postoperative follow-up
Animals did not fast the night prior to surgery. All animals were anaesthetized with Isoflurane (Forane ® , Abbott SpA, Campoverde di Aprilia, Italy) at 1.5-2% with oxygen, supplemented with 5 mg/kg of tramadol. The animal was placed supine over a cork tray with its caudal part towards the surgeon, after being shaved along the midline for 2 cm width from the sternum to 2 cm above the genital area and disinfected. A median longitudinal incision was performed and two mini retractors were used to keep the abdomen open. The patch was placed on the abdominal aorta, halfway between the renal vessels and the iliac bifurcation. The abdominal aortic portion included in the clamp's jaws was grasped gently with the forceps, and a small elliptical aortectomy was performed with the fine tip scissors so as to excise part of the aortic anterior wall. A CorMatrix ECM ® patch (tailored as above-mentioned) was sutured to the anterior aortic wall with a 8/0 Prolene running suture. Two strips of gelatin sponge were applied over the suture lines to ensure haemostasis before declamping. The abdomen was closed in two layers with a 3/0 running suture. A long-acting antibiotic (Terramycin ® -L.A, Pfizer Italiana SpA, Latina, Italy; 60 mg/kg in 5 ml of saline) was subcutaneously administered to the animal for infection prophylaxis and hydration. The animal was placed under a heating lamp and monitored visually until it was fully awake (up to 5 min after anaesthesia). The animal was then left to recover at a room temperature of 22-24°C, together with other animals, with immediate, unrestricted access to food and water. Intramuscular tramadol, at a dose of 5 mg/kg, was used to control postoperative pain twice daily for the first 48 postoperative hours. The health status and the body weight were followed up daily on a regular basis. Sacrifice was planned randomly at approximately 15, 30, 90 and 180 days post-surgery. The infra-diaphragmatic abdominal aorta was explanted until the iliac bifurcation, preserved in formalin and sent for histopathological study.
Histological study
Formalin-fixed artery segments were embedded in paraffin and longitudinal 4-5 µm wide sections were obtained and stained with haematoxylin and eosin (H&E) for traditional histology and morphometry. Elastic Fibre van Gieson (EVG) was performed to identify the elastic lamina and the arterial structures and to define the insert point of the CorMatrix ECM ® patch. Parallel sections were prepared for immunohistochemical analysis (see 'Immunohistochemistry and double immunofluorescence study' section, below.).
Morphometric analysis and measurements were performed by means of validated techniques currently applied in our lab, which have been described elsewhere [9, 10] . We employed a computerized image analyzer system consisting of an optic microscope (Olympus BH2), computer connected to a video camera ( JVC 3-CCD, Japan) and a software for image analysis (Image PRO-Plus 4.0, Media Cybernetics, Silver Spring, MA, USA).
Immunohistochemistry and double immunofluorescence study
Immunohistochemical single and double stains were performed on 5-µm thick sections prepared from formalin-fixed, paraffin-embedded tissue, according to the standard procedures described elsewhere [1] . The antibodies used were GFP-specific antibody (1:1000, Abcam, UK) to identify and amplify GFP recipient-positive cell signals, CD45 T-cell antigen (Chemicon Millipore, USA), CD68 (macrophages, Chemicon Millipore, USA), alfa von Willebrandt factor (vWF, Chemicon Millipore, USA) and anti-smooth muscle actin (SMA, 1:50, DakoCytomation, Dako, Italy) for vessel and myoblast cells.
For double immunofluorescence study, bound antibodies were visualized with anti-mouse or anti-rabbit fluorescein isothiocyanate-or rhodamine-conjugated secondary antibodies. Nuclei were stained with TO-PRO3 (Invitrogen, Molecular Probes, CA, USA). Microphotographs were then taken using a TCS-SL laser scanner confocal microscope (Leica, Germany) [9, 10] . Double colorimetric staining with EVG and anti-SMA was performed as follows: all sections were deparaffinized in alcohol (100%) and incubated to 55°C in Weigert solution for 45 min. After hydration in water, sections were incubated with the primary antibody SMA (DakoCytomation) for 1 h at room temperature. After washing, a biotin-conjugated goat anti-mouse immunoglobulin (Southern Biotech) was applied. Vector Blue was used as a chromogen. Finally, all sections were incubated in Van Gieson solution for 10 min and washed. Control positive sections of tonsil or bone marrow biopsy from autopsies were included for each antibody in each immunostaining session.
Semi-quantitative analysis of cells
To analyse the cellular response to treatments, microscopic examinations were performed on immunostained sections. Cells were identified by haematoxylin and eosin staining for inflammatory cells, immunohistochemical staining for endothelial cells ( positive for von Willebrand factor), muscle cells ( positive for anti-SMA) and elastic fibres (Weigert's elastin stain). Briefly, two investigators analysed at least three slides for each experiment by light microscopy using ×20 as the initial magnification looking at all specimens. Cells were scored from not present (−) to abundantly present (+++) [11] .
RESULTS
Patch morphology before implantation
By dry-weight, the SIS-ECM is composed of collagen for >90% as shown by EVG staining (Fig. 1a-c) . We observed the characteristic features of SIS, which is usually rich in cell nuclei and reactive to smooth muscle cell antigen ( Fig. 1d and e) . The presence of cell nuclei was confirmed by TO-PRO counterstaining and confocal microscopy (Fig. 1f ) . The counterstain showed that chromatin was not well organized but was visible as a smear, which is evidence of cell nuclei inactivation.
Animal surgical results
Overall, 21 adult male Sprague Dawley rats and 5 GFP rats were tested. Three Sprague Dawley animals were sacrificed at a mean weight of 266 g, as control cases, in order to evaluate histology, morphology and immunohistochemistry in normal murine aorta to be used as a term of comparison ( Fig. 2A) .
Three Sprague Dawley animals were sham-operated. They all survived after surgery and were sacrificed 45 days after the operation. Their postoperative course was uneventful and the average weight increase was 146.6 g (149%, 3.3 g/day).
In all other animals, the SIS CorMatrix ECM ® patch implantation was successfully performed with no operative complications, with a mean cross-clamping time of 25 min (range 18-35 min). Fifteen Sprague Dawley rats had a patch implantation and were sacrificed as follows: Group A, nine animals (seven sacrificed at 15 days, two at 30 days); Group B, six animals (one sacrificed at 3 months, five at 6 months). The same experiment was performed in five GFP animals (Group C) in whom surgery was uneventful; among these, sacrifice was done at 15 days (one animal), at 1 month (one animal) and at 6 months (four animals).
Normal murine arterial wall architecture
All control (natural and sham-operated) rats were analysed in order to define the architecture and markers' distribution in arteries. At pathological and histological analysis (H&E, EVG and SMA staining), the arterial wall architecture of sham-operated animals was comparable with that of natural controls ( Fig. 2A) .
CorMatrix (small intestine submucosa extracellular matrix) remodelling after implantation
All animals were sacrificed as described above. No significant graft aneurysm was detected. The aortic wall was shown to be intact in all cases examined. The histological evaluation confirmed the arterialization process in the absence of inflammation (Fig. 2B) . No calcific degeneration was evident in all samples.
The patch wall showed a significant presence of a new rim of SMA-positive cells, with a typical feature of fusated cells underlining the aortic lumen, and acting as neoaortic wall cells (Fig. 2Bb and c) . The thickness of the proliferation/migration cell layer did not overwhelm the overall patch thickness. This was combined with a significant neoangiogenetic remodelling of the adventitial layer. Finally, immunohistochemistry demonstrated a strong expression of von Willebrandt factor, which was evidence of re-endothelialization (Fig. 2Bd) .
Following these preliminary results, the same experiment was performed in other five GFP animals, in order to define whether the new intima and media layer were originating from the donor or from the recipient. Surgery was uneventful and all animals survive well, with excellent growth. One animal was sacrificed at 15 days after surgery, one at 1 month and four at 6 months after surgery.
No significant graft aneurysmatic dilatation or detachment was present. The aortic wall was found to be intact in all. These results were confirmed also by microscopic analysis and histology. The confocal microscopy highlighted that smooth muscle cells were colonizing the patch, and well-differentiated endothelial cells (vWf positive) were discountinuously lining the lumen of the patch since 15 days after implant (Fig. 3) . The centre of the graft showed an intimal hyperplasia with the presence of contractile spindle-shaped positive cells for SMA. Both new endothelial cells and SMA cells were GFP positive, suggesting their recipient origin (Fig. 3) . At 30 and 60 days after implantation, the graft was still present, but new SMA-positive cells were well organized to form a vascular layer. Moreover, the luminal surface of the graft was repopulated by a continuous thin layer of vWF-positive endothelial cells from 30 days after surgery (Fig. 3) . The graft was almost completely remodelled 180 days after implantation, and it was not possible to identify the original collagen structure anymore (Fig. 4a-c) .
The SIS-ECM patch remodelling (Fig. 4d-h ) was suggested by the presence of new rim of smooth muscle cells and of neoangiogenesis in the adventitia (Fig. 4f-h ). CorMatrix ® SIS-ECM patch confocal immunofluorescence vWf staining showed the complete endothelialization of the patch by GFP differentiated cells (Fig. 4h) .
Cellular response to the extracellular matrix graft
Cellular events involved in in vivo arterial regeneration are summarized in Table 1 . After 15 days, the graft showed scanty infiltration of macrophages. No elastic fibres were observable in any patch. The moderate endothelial cell repopulation was present. After 30 days, the cellular response included a significant amount of endothelial cells and smooth muscle cells. From 60 to 180 days, the new generated tissue showed a large amount of both endothelial and smooth muscle cells. No elastic fibres were observed.
DISCUSSION
The most innovative finding in our study is the clear histopathological evidence of regeneration and remodelling of the neoaorta of the SIS-ECM vascular graft in a murine model. This study has been solicited by the need of regenerative biological tissues for vascular and cardiac structures in paediatric patients with congenital cardiac disease, who often need reoperation because of a mismatch between prosthetic materials and the child's growth. Tissue engineering is currently facing this issue with many research studies.
Biological scaffold materials composed of ECM have been shown to facilitate the constructive remodelling of many different tissues in both preclinical animal studies and in human clinical applications [8] . ECM scaffolds consist of the structural and functional molecules secreted by the resident cells of each tissue and organ from which they are prepared. Therefore, the specific composition and distribution of the ECM constituents will vary depending on the tissue source [12] . The mechanisms by which biological scaffold materials promote site-appropriate tissue reconstruction are not yet well understood, and there is legitimate controversy concerning the relevant importance of the composition vs the structure of these materials.
A number of different products available in the market are used in reconstructive surgery for various tissues and organs. In our own institution, we have analysed the potential capabilities of regeneration of the SIS-ECM CorMatrix ® . This material is made from small intestinal submucosa derived from pig jejunum and has been already used as an acellular biological scaffold in many different surgical applications [4] [5] [6] [7] . In its natural form, the ECM consists primarily of several types of collagens, with smaller, but significant, amounts of glycosaminoglycans, glycoproteins and growth factors [13, 14] , as has been also demonstrated by our analysis on the pre-implant original patch. To transform this naturally occurring material in a utilizable, nonimmunogenic patch, all cells must be removed or inactivated. Our analysis has shown that the characteristic structure of SIS was preserved, but chromatin was not well organized, still visible as a smear, as an evidence of cell nuclei inactivation.
The SIS-ECM material (CorMatrix®) is composed also by proteoglycans and other non-fibrillar support structures (such as hyaluronic acid), which are very important for the healing processes. Hyaluronic acid is thought to help regulate the matrix density and inhibit scar formation during the healing process. Recently, modified hyaluronan biomaterials have been prepared for the culture of chondrocytes and bone marrow-derived mesenchymal cells for cartilage and bone defects [15] . Moreover, human endothelial and smooth muscle cells have been grown in vitro on hyaluronic acid biomaterial constructs with the objective to develop a new tissue-engineered vascular substitute [16] .
Histological analysis has confirmed the ability of SIS-ECM to create a suitable environment during tissue regeneration. In fact, after implantation, all tissues adjacent to the ECM matrix deliver cells and nutrients, and the matrix itself recruits circulating bone marrow-derived cells which can then differentiate into tissuespecific cells [16] . In our experience, this phenomenon was present as soon as 15 days from implantation as shown in Fig. 3 . In fact, the implanted ECM patch acted like a scaffold into which the hosting organism cells migrated and integrated, stimulating the natural wound-healing mechanisms and promoting the anchoring of endothelial progenitor cells onto its surface, favouring the regeneration process. The graft is gradually replaced as the host tissue gradually turns over in a natural state of selfrenewal as shown in Fig. 4 .
Microscopic features of the matrix play important roles in modulating the behaviour of cells that contact the scaffold by controlling the cells' ability to migrate into the scaffold itself [12] . The basement membrane and regular/irregular collagen surface architecture can facilitate the penetration of selected cell types into the ECM scaffold, so that it can affect the migration and differentiation pathways of human stem cells and selected progenitor cell population [17] [18] [19] .
Previous dated studies [8, 14, 15] have confirmed that acellular ECM, when used as a scaffold for tissue reconstruction, could be populated by organized and differentiated cell types instead of replacement of the scaffold by scar tissue or collagen. Similarly, in our experience for the first time, the SIS-ECM has acted as an excellent substrate for endothelial cell growth, migration and proliferation of smooth muscle cells in vascular reconstruction. In addition, we were able to demonstrate not only the repopulation by differentiated cells, but also the tridimensional regeneration of the normal natural aortic layers. In fact, the new aortic wall presented with a 'tunica intima' composed by an endothelial lining, a 'tunica media' with smooth muscle cells and 'an adventitia' containing vessels and fibroblasts. The remodelled scaffold showed complete degradation and reabsorption of the originally implanted SIS-ECM material and replacement by host tissues at 6 months post-transplantation (Fig. 4) .
Concern for mechanical resistance usually arises in the clinical setting when new materials are used for arterial wall plasty or reconstruction. Decellularized tissues are expected to have all cellular and nuclear material efficiently removed while maintaining a similar composition, biological activity and mechanical integrity of the ECM [20] . Thus, mechanical properties are under question. In previous mechanical studies on decellularized materials, loading has been limited to uniaxial stretching or planar biaxial tensile tests [21, 22] . Although it cannot fully replicate the physiological loading conditions, a biaxial tensile test is sufficient for elucidating the anisotropic mechanical properties of soft tissues with plane stress assumptions, which is important for the in vitro understanding of tissue mechanics. In our experimental surgical sample, the SIS-ECM graft was sutured on the abdominal aorta and no aneurysm was evidenced macroscopically at planned sacrifice. We have not tested this ECM material in vitro. However, Zou and Zhang [23] have recently reported on the mechanical properties of ECM materials after decellularization, concluding that they exhibited similar elastic properties as intact aortas under biaxial tensile testing; furthermore, non-obvious creep behaviour was found in decellularized and native porcine aorta samples. Thus, in our opinion, it is reasonable to believe that this material can be at least comparable to currently available prosthetic materials. As far as aneurysm formation is concerned, it is not possible to predict the long-term performance of such materials at this current state of the art. Similarly, the calcific degeneration that affects various prosthetic materials in the long-term is not predictable in an ECM graft. However, we can certainly state that in our animal experience, there is no evidence of calcification at explantation even 6 months after surgery.
Finally, these experimental results seem to confirm the regeneration capabilities of this material and allow a reasonably safe use in humans. Scholl et al. [3] have published their own preliminary experience with repair of congenital heart disease using the ECM CorMatrix patch in several children with congenital heart disease, with excellent early results. The material has resulted to be pliable and haemostatic. No patch-related complications have been reported so far. Thus, in light of our findings and clinical reports published in the literature [3, 24] , the SIS-ECM patch may represent an effective and safe material for the repair of congenital heart and vascular diseases in children and young adults, so as to avoid the need of reoperation caused by the prosthetic material-child growth mismatch. Based on this experience, we have started using this material for pulmonary artery reconstruction and pulmonary valve leaflet reconstruction in congenital cardiac disease such as the tetralogy of Fallot, in which conventional repair precludes a normal pulmonary valve function [25] , with excellent early-term outcomes.
The most significant limitation of this animal study is the lack of information in the first 2 weeks after surgery since the first animals were sacrificed at 15 days. The successful utilization of the mammalian-ECM biomaterial as a therapeutic device will depend also on understanding the relationship of native structure and first cells migration events in the scaffold. In addition, due to the experimental nature of the study itself, this result in the experimental setting has to be evaluated carefully for the clinical setting. The SIS-ECM patch used for our animals was only 6 mm long, a size which is not even considerable for the human setting. We demonstrated recolonization of host cells just after a few weeks in our animals. It is not possible to predict how long colonization may take in clinical practice, neither if a longer time of colonization could increase the risk of aneurysm formation.
In conclusion, we report the evidence of vascular tissue regeneration and remodelling after SIS-ECM CorMatrix ® patch implantation in a murine model. Our research experience suggests that this material may be employed effectively for vascular and also intracardiac reconstruction in paediatric patients, in order to avoid the negative drawback of multiple reoperations. 
